We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.

Sandbox Reserved 1165

From Proteopedia

(Difference between revisions)

Jump to: navigation, search

Revision as of 13:16, 22 March 2016

[[Image:]]

This Sandbox is Reserved from Jan 11 through August 12, 2016 for use in the course CH462 Central Metabolism taught by R. Jeremy Johnson at the Butler University, Indianapolis, USA. This reservation includes Sandbox Reserved 1160 through Sandbox Reserved 1184.

To get started:

Click the edit this page tab at the top. Save the page after each step, then edit it again.
Click the 3D button (when editing, above the wikitext box) to insert Jmol.
show the Scene authoring tools, create a molecular scene, and save it. Copy the green link into the page.
Add a description of your scene. Use the buttons above the wikitext box for bold, italics, links, headlines, etc.

More help: Help:Editing

Human Glucagon Class B G Protein-Coupled Receptors (GPCRs)

1 Introduction
2 Structure
3 Extracellular Tips
4 How These Structures Lead to Function

Introduction

, also known as secretin-like receptors, are a subfamily of the more well known class A (rhodopsin-like) glucagon receptor family. Located in the liver, class B glucagon receptors (GCGRs) are activated by the binding of the hormonal peptide glucagon which leads to the release of glucose into the bloodstream and plays an essential role in glucose homeostasis. Class B GCGRs are composed of a seven transmembrane domain (7TM) and extracellular domain (ECD) that are of vital importance in glucagon binding. In comparison, class A vs. class B glucagon receptors share less than fifteen percent sequence homology, but both share this 7TM which is a primary area of comparison between the two.

Structure

Secretin-like receptors are composed entirely of alpha helices in their 7TM and ECD. A distinct feature of class B receptors is the N-terminal end of helix one in the 7TM. It extends an extra three helical turns into the ECD, and is longer than any of the class A receptors. This region, referred to as the "stalk" of class B receptors, is highly involved in glucagon binding and also helps in defining the orientation of the ECD with respect to the 7TM domain.

Extracellular Tips

The locations of the extracellular tips for class B glucagon receptors allow for a much wider and deeper binding cavity in the ligand-binding pocket, which is much more immense than any of the class A GCGRs. These wide ranges specifically occur between alpha helices two and six (green) and three and seven (red).

How These Structures Lead to Function

Structurally, the N-terminal extracellular domain (ECD) and the 7TM comprise the signature seven helical structure that is involved in signaling via coupling to heterotrimeric proteins that activate adenylate cyclase to increase the levels of intracellular cyclic AMP, and also heterotrimeric G proteins that increase inositol phosphate and intracellular calcium levels. The wider and deeper ligand-binding pocket of class B GPCRs allows for a vast array of receptors to be bound that allow for numerous functions activated by peptide receptors. The conformation and orientation of the 7TM and the ECD regions dictate the functionality of the protein.There is an open and closed conformation of the GCGR. When glucagon binds to GCGR, the open conformation of GCGR is stabilized. There is no clear binding site location of the hormone peptide ligand. They do know the N-terminus of glucagon binds deep into the binding pocket.The amino acids at the N-terminus have the ability to form hydrogen bonds and ionic interactions.

Image:Amino Acid Sequence.jpg

Many of the residues that are in direct contact with the glucagon molecule are charged or are polar. There are also any bulk resides on glucagon that support the bulky resides on the GCGR. These residues are located within the binding pocket of the 7TM. There are specific amino acid interactions that hold the helices of the 7TM in the conformation that maximizes affinity, this includes a disulfide bond between Cys 294 and Cys 224 that serves to hold the ECL1 and ECL2 in the proper orientation.Also, the salt bridges between Glu 406, Arg 173, and Arg 346 that hold the conformation of affinity. Alpha helical structure of the stalk is imperative to the affinity and binding of the glucagon.

Clinical Relevancy

Of the fifteen human class B GPCRs, eight have been identified as potential drug target^[1]. Therapeutic agents have been created from the peptides themselves within this protein, but overall pharmaceutical companies have had difficulty creating agents that act on family B GPCRS. There is an outward appearance and inherent flexibility in the class B GCGR 7TM because of conserved hydrogen bonds that flank a glycine residue, and this structure along with the ECD and its role of interactions on the extracellular side of receptors may provide evidence to how class B receptors adjust its conformational spectra for various receptors. Researchers hope to show how these conformations can be utilized in potential treatments of a wide array disorders.

References

↑ Bortolato A, Dore AS, Hollenstein K, Tehan BG, Mason JS, Marshall FH. Structure of Class B GPCRs: new horizons for drug discovery. Br J Pharmacol. 2014 Jul;171(13):3132-45. doi: 10.1111/bph.12689. PMID:24628305 doi:http://dx.doi.org/10.1111/bph.12689

Retrieved from "http://52.214.119.220/wiki/index.php/Sandbox_Reserved_1165"

@@ Line 30: / Line 30: @@
 </StructureSection>
 ==Clinical Relevancy==
-Of the fifteen human class B GPCRs, eight have been identified as potential drug target. Therapeutic agents have been created from the peptides themselves within this protein, but overall pharmaceutical companies have had difficulty creating agents that act on family B GPCRS. There is an outward appearance and inherent flexibility in the class B GCGR 7TM because of conserved hydrogen bonds that flank a glycine residue, and this structure along with the ECD and its role of interactions on the extracellular side of receptors may provide evidence to how class B receptors adjust its conformational spectra for various receptors. Researchers hope to show how these conformations can be utilized in potential treatments of a wide array disorders.
+Of the fifteen human class B GPCRs, eight have been identified as potential drug target<ref name="Drug">PMID: 24628305</ref>. Therapeutic agents have been created from the peptides themselves within this protein, but overall pharmaceutical companies have had difficulty creating agents that act on family B GPCRS. There is an outward appearance and inherent flexibility in the class B GCGR 7TM because of conserved hydrogen bonds that flank a glycine residue, and this structure along with the ECD and its role of interactions on the extracellular side of receptors may provide evidence to how class B receptors adjust its conformational spectra for various receptors. Researchers hope to show how these conformations can be utilized in potential treatments of a wide array disorders.
 == References ==
 <references/>

Sandbox Reserved 1165

From Proteopedia

Revision as of 13:16, 22 March 2016

Human Glucagon Class B G Protein-Coupled Receptors (GPCRs)

Contents

Introduction

Structure

Extracellular Tips

How These Structures Lead to Function

Clinical Relevancy

References

Views

Personal tools

Navigation

Search

Toolbox